Spots Global Cancer Trial Database for Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients
Official Title: R-CHOP Therapy Compared With R-CHOP Plus Biocell Natural Killer Mixture in Patients With DLBCL (Diffuse Large B Cell Lymphoma);A Randomized, Open-label,Multi-center Trail
Study ID: NCT00846157
Conditions
Interventions
Study Description
Brief Summary: Primary objective: * To compare the event free survival for 3years of R-CHOP plus Biocell Natural Killer Cell to R-CHOP therapy with DLBCL patients.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Catholic University of korea, Banpo-Dong 505, Seoul, Korea, Republic of
Contact Details
Name: Seok-Goo Cho, MD,PhD
Affiliation: Catholic Hematopoietic Stem Cell Transplantation Center in The Catholic University of Korea
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
